Screener / SEC EDGAR /CIK 0000908255 /10-K filed Feb 11, 2026, compared with Feb 6, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Consumer discretionary · Auto Parts

Borgwarner Inc BWA

Compare with peers Embed
SEC comment letters, last 20 years

2 reviews of BWA's filings by SEC staff

UPLOAD and CORRESP
Reviews 2 latest letter Dec 19, 2022
Questions asked 21 each answered in the company's own letter
No closing letter 0 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 5 UPLOAD
  2. 2. Questions in them 21 numbered comments
  3. 3. Company replies 5 CORRESP
  4. 4. Reviews closed 2 of 2 closing letter

Half the closed reviews took 522 days or less from the first letter to the closing letter.

Form 10-K for the Fiscal Year Ended December 31, 2021

2022-12-19 to 2023-01-12 · 1 question · 1 letter from the SEC, 1 from the company
Review closed 2023-01-12
RevenueResults discussion (MD&A)Acquisitions
Management's Discussion and Analysis of Financial Condition and Results of Operations · Results of Operations, page 36
SEC asked
Please expand your discussion of your result of operations to provide a more comprehensive and quantified discussion and analysis of the factors that impacted your results between comparative periods. Please revise your future annual and quarterly filings to provide the following: • Expand your discussion of net sales to quantify how much of the increase in net sales was due to changes in volume, changes in selling
Rest of the question

prices and changes in product mix. Please also discuss and quantify the impact of market demand and favorable pricing including the impact of the recovery of global markets from the negative effects of COVID-19 on 2020 production. Given your increase of 46% in net sales from the year ended December 31, 2020, please quantify and explain how your supply chain constraints negatively impacted your net sales from period to period; • Expand your discussion of gross profit to quantify the impact of the business factors that affected your gross profit including the impact of your higher warranty provision and increases in commodity and other costs. Please consider discussing the impact of product mix and raw material pricing and details of other costs that impacted your gross profit; • Please enhance your disclosure throughout your MD&A to quantify the business reasons for the changes between periods in the significant line items of your statements of income. Please also enhance your disclosure to quantify the majority of the change in your significant line items, including the impact of offsetting factors where applicable. For example, selling, general and administrative expenses increased by $509.0 million from $951.0 million in 2020 to $1,460.0 million in 2021, however you have only quantified the increase of $200 million related to the acquisition of Delphi Technologies; and • We note that you discussed the impact of inflation in greater detail in your earnings call for the quarterly period ended September 30, 2022. Please revise your discussion to describe and quantify how inflation has affected your revenues, costs and margins, explaining the relative effect of each. This is not meant to represent an all-inclusive list of where your MD&A could be improved. We encourage you to provide quantification of amounts and further clarification throughout your discussion. Refer to Item 303 of Regulation S-K and Section III.B.4 of Release No. 33-8350 for guidance.

BWA answered
The Company respectfully acknowledges the Staff’s comment. In response, our future quarterly and annual filings beginning with our Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2022, will include enhanced discussion of our results of operations. This will include providing a more comprehensive and quantified discussion and analysis of the factors that impacted our results between comparative periods.

By way of illustration, we provide below an example of our enhanced comparative period disclosures for significant financial statement line items as if it had been included
Rest of the answer

in our Quarterly Report on Form 10-Q for the nine months ended September 30, 2022. Please note that the Company considers a combination of volume, mix and net new business when evaluating performance and presenting results to the investment community. The Company currently estimates and reports how much of its sales were generated from changes in weighted average market production, which is further described in the example below, and how much of its sales were generated from its performance relative to that market production. The example below uses this same approach.

We have excluded disclosures relating to the three months ended September 30, 2022 from the illustrative example below; however, we will include enhanced comparative disclosures for all quarterly and year-to-date periods presented in future filings. Additionally, certain disclosures from the 2021 Form 10-K, such as the higher warranty provision due to an unfavorable settlement, are not included in the example as they were not applicable to the periods presented. Textual changes have been marked for your convenience (underlined text represents newly added disclosures).

Nine Months Ended September 30, 2022 vs. Nine Months Ended September 30, 2021

Net sales

Net sales for the nine months ended September 30, 2022 totaled $11,693 million, an increase of $510 million, or 5%, from the nine months ended September 30, 2021. The change in net sales for the nine months ended September 30, 2022 was primarily driven by the following:

•Favorable volume, mix and net new business increased sales approximately $751 million, or 7%. This increase was primarily driven by higher weighted average market production as estimated by the Company, which was up approximately 4% from the nine months ended September 30, 2021. The remaining increase primarily reflects the sales growth above market production, which the Company believes reflects higher demand for its products. Weighted average market production reflects IHS light and commercial vehicle production weighted for the Company’s geographic exposure, as estimated by the Company.

•Customer pricing increased net sales by approximately $395 million. This includes an increase of approximately $385 million related to recoveries from the Company’s customers of material cost inflation arising from non-contractual commercial negotiations with those customers and normal contractual customer commodity pass-through arrangements.

•Foreign currencies resulted in a year-over-year decrease in net sales of approximately $654 million primarily due to the weakening of the Euro, Korean Won and Chinese Renminbi relative to the U.S. Dollar.

•Acquisitions, primarily AKASOL, contributed $124 million in additional net sales in the nine months ended September 30, 2022. In December 2021, the Company sold its Water Valley, Mississippi manufacturing facility, which accounted for $137 million of net sales in the nine months ended September 30, 2021 that did not recur in 2022.

Cost of sales and gross profit

Cost of sales and cost of sales as a percentage of net sales were $9,425 million, or 80.6%, during the nine months ended September 30, 2022, compared to $8,953 million, or 80.1%, during the nine months ended September 30, 2021. The change in cost of sales for the nine months ended September 30, 2022 was primarily driven by the following:

•Higher sales volume, mix and net new business increased cost of sales by approximately $654 million.

•Cost of sales was also impacted by material cost inflation of approximately $467 million arising from non-contractual commercial negotiations with the Company’s suppliers and normal contractual supplier commodity pass-through arrangements. This impact was partially offset by $185 million of supply chain savings initiatives.

•Foreign currencies resulted in a year-over-year decrease in cost of sales of approximately $542 million primarily due to the weakening of the Euro, Korean Won and Chinese Renminbi relative to the U.S. Dollar.

Gross profit and gross margin were $2,268 million and 19.4%, respectively, during the nine months ended September 30, 2022 compared to $2,230 million and 19.9%, respectively, during the nine months ended September 30, 2021. The decrease in gross margin was primarily due to the cost of sales increases discussed above.

Selling, general and administrative expenses (“SG&A”)

SG&A for the nine months ended September 30, 2022 was $1,179 million as compared to $1,084 million for the nine months ended September 30, 2021. SG&A as a percentage of net sales was 10.1% and 9.7% for the nine months ended September 30, 2022 and 2021, respectively. The change in SG&A was primarily attributable to:

•Increased research and development (“R&D”) costs of $64 million. R&D costs, net of customer reimbursements, were 5.1% of net sales, for the nine months ended September 30, 2022, compared to 4.8% of net sales, for the nine months ended September 30, 2021. The increase in R&D costs, net of customer reimbursements, was primarily due to increasing net investment related to the Company’s electrification product portfolio.

•Increased administrative expenses, primarily IT, of $43 million.

•Decreased employee-related costs of $17 million, primarily related to incentive compensation.

Restructuring expense was $50 million and $143 million for the nine months ended September 30, 2022 and 2021, respectively, primarily related to employee benefit costs. Refer to Note 5 “Restructuring” to the Condensed Consolidated Financial Statements in Item 1 of this report for more information.

During 2022, the Company approved individual restructuring actions that primarily related to specific reductions in headcount. During the nine months ended September 30, 2022, the Company recorded $18 million related to these actions.

In February 2020, the Company announced a $300 million restructuring plan to address existing structural costs. During the nine months ended September 30, 2022 and 2021, the Company recorded $28 million and $81 million of restructuring charges related to this plan, respectively. Cumulatively, the Company has incurred $279 million of restructuring charges related to this plan. As of September 30, 2022 the plan is substantially complete, with any remaining restructuring costs expected to be incurred by the end of 2022. The resulting annual gross savings are expected to be in excess of $100 million and will be utilized to sustain overall operating margin profile and cost competitiveness.

Other operating expense, net was $26 million and $30 million for the nine months ended September 30, 2022 and 2021, respectively.

For the nine months ended September 30, 2022 and 2021, merger, acquisition and divestiture related expenses, net were $40 million and $36 million, respectively. The increase in 2022 was primarily related to professional fees associated with specific acquisition and disposition initiatives.

During the nine months ended September 30, 2022, the Company recorded a pre-tax gain of $24 million in connection with the sale of its interest in BorgWarner Romeo Power LLC (“Romeo JV”), in which the Company owned a 60% interest. Refer to Note 3, “Acquisitions,” to the Condensed Consolidated Financial Statements in Item 1 of this report for more information.

Other operating expense, net is primarily comprised of items included within the subtitle “Non-comparable items impacting the Company’s earnings per diluted share and net earnings” below.

Equity in affiliates’ earnings, net of tax was $29 million and $40 million for the nine months ended September 30, 2022 and 2021, respectively. This line item is driven by the results of the Company’s unconsolidated joint ventures.

Unrealized loss on equity securities was $27 million and $337 million for the nine months ended September 30, 2022 and 2021, respectively. This line item reflects the net unrealized gains or losses recognized due to recording the Company’s investments at fair value, and the 2021 amount was primarily related to the Company’s investment in Romeo Power, Inc. In the nine months ended September 30, 2022, the Company sold all of its remaining investment in Romeo Power, Inc. For further details, see Note 3, “Acquisitions,” to the Condensed Consolidated Financial Statements in Item 1 of this report.

Interest expense, net was $42 million and $75 million for the nine months ended September 30, 2022 and 2021, respectively. The decrease in interest expense, net was primarily due to the $20 million loss on debt extinguishment recorded in 2021 that related to the early repayment of the Company’s €500 million 1.800% senior notes settled on June 18, 2021.

Provision for income taxes was $252 million for the nine months ended September 30, 2022, resulting in an effective rate of 25%. This is compared to $149 million, an effective rate of 24%, for the nine-month period ended September 30, 2021.

During the nine months ended September 30, 2021, the Company recognized a $55 million tax benefit related to a reduction in certain unrecognized tax benefits and accrued interest for a matter in which the statute of limitations had lapsed. The Company also recognized a discrete tax benefit of $20 million related to an increase in its deferred tax assets as a result of an increase in the United Kingdom (“UK”) statutory tax rate from 19% to 25%. Further, the Company’s effective tax rate for the nine months ended September 30, 2021 included a net discrete tax benefit of $33 million, primarily related to changes to certain withholding rates applied to unremitted earnings. The effective tax rate was unfavorably impacted by $179 million of restructuring expenses and merger, acquisition and divestiture expenses, some of which were largely non-deductible for tax purposes. The Company recognized $22 million of tax benefit associated with these expenses in the nine months ended September 30, 2021.

Read in the reply
In its next report

First report after the company's reply of Jan 6, 2023: 10-K filed Feb 9, 2023 ↗, against the 10-K filed Feb 15, 2022 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2023-01-12

Form 10-K

2017-05-11 to 2018-10-15 · 20 questions · 4 letters from the SEC, 4 from the company
Review closed 2018-10-15
Legal and contingenciesResults discussion (MD&A)
Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked
We note your disclosure that you have made enhancements to the management and analysis of asbestos-related claims, including the engagement of new national coordinating council and new local counsel panels, outsourcing administration and claims handling, implementing improvements in processing, and increasing audits and compliance reviews of counsel handling asbestos-related claims.
Rest of the question

You state that this has resulted in improvements in both the quantity and quality of information available and an increased ability to reasonable forecast the number of potential future claims that may be asserted. You also state that you hired a third party consultant in the third quarter of 2016 to further assist you in the analysis of potential future asbestos-related claims. It appears that with the assistance of this external consultant and the updated data and analysis resulting from your claims review process, you determined that your best estimate of the aggregate liability both for asbestos-related claims asserted but not yet resolved and potential asbestos-related claims not yet asserted, including an estimate for defense costs, is $879.3 million as of December 31, 2016, which is $770.8 million higher than the prior year. Please tell us your consideration of accounting for this as a correction of an error in previously issued financial statements rather than as a change in estimate. Refer to ASC 25010-20.

BWA answered
The Company concluded that its revised estimate for asbestos-related claims is a change in accounting estimate rather than a correction of an error in previously issued financial statements because the quarter ending December 31, 2016 is the first time that the liability attributable to potential asbestos-related claims not yet asserted could be reasonably estimated, as required for the accrual of a charge under ASC 450-20-25-2(b).

A change in accounting estimate is defined in ASC 250-10-20 (in relevant part) as

[a] change that has the effect of adjusting the carrying amount of an existing
Rest of the answer

asset or liability or altering the subsequent accounting for existing or future assets or liabilities. A change in accounting estimate is a necessary consequence of the assessment, in conjunction with the periodic presentation of financial statements, of the present status and expected future benefits and obligations associated with assets and liabilities. Changes in accounting estimates result from new information.

In comparison, an Error in Previously Issued Financial Statements is defined in ASC 250-10-20 (in relevant part) as

[a]n error in recognition, measurement, presentation, or disclosure in financial statements resulting from mathematical mistakes, mistakes in the application of generally accepted accounting principles (GAAP), or oversight or misuse of facts that existed at the time the financial statements were prepared.

The Company has historically reviewed, on an ongoing basis, its asbestos claims experience and trends affecting asbestos-related claims in the U.S. tort system generally, for, among other purposes, assessing the estimated value of asbestos-related claims that have been asserted or may be asserted in the future against the Company. For periods through and including the third quarter of 2016, the Company was able to make a reasonable estimate of indemnity and defense costs for asbestos-related claims asserted against the Company but not yet resolved, and accrued a liability for such estimated amount, in accordance with ASC 450-20-25-2. For those periods, the Company also concluded that its claims data was too volatile, and the circumstances in which future asbestos-related claims would be resolved too uncertain, to support a reasonable estimate of the liability for potential asbestos-related claims not yet asserted based on the facts known to the Company at that time. Those facts, which were included in the Company’s contemporaneous securities filings, included:

• the Company’s unique profile as a defendant in asbestos-related lawsuits, given that its asbestos-containing products utilized encapsulated asbestos, were manufactured no later than the mid-1980s, and had limited useful lives, which made it difficult to identify claimants legitimately exposed to the Company’s products and suggested that exposures relating to such products should be smaller in number and trend downward quickly as compared to general asbestos industry trends, resulting in fewer future claims compared to defendants with different historical products and usage, the number and types of asbestos-related claims asserted against the Company, uncertainty of future disease incidence and claiming patterns in claims asserted against the Company, changes in asbestos-related litigation in the United States, the significant number of co-defendants that had filed for bankruptcy protection, and the magnitude and timing of co-defendant bankruptcy trust payments to claimants.

All of these factors together made the Company’s claims data volatile and limited the relationship of the Company’s claims data to industry data, which in turn precluded the Company from being able to reasonably estimate the likely number and types of potential future asbestos-related claims that might be asserted against the Company. Because a reasonable estimate could not be made, the Company did not accrue a liability on account of such potential future claims during the applicable periods, but instead provided disclosure of the loss contingency in its financial statements, in accordance with ASC 450-20-25-2 and ASC 450-20-50.

The Company re-evaluated its ability to reasonably estimate its potential liability for future asbestos-related claims consistently during periods prior to the fourth quarter of 2016. That re-evaluation was performed by the Company’s Risk Management department, and was reviewed by the Chief Financial Officer and discussed with the Audit Committee of the Company’s Board of Directors on a quarterly basis.

In connection with the preparation of its annual financial statements for 2016, the Company was able to determine for the first time that its potential liability for asbestos-related claims not yet asserted was capable of reasonable estimation. That determination became possible at such time for several reasons:

during 2016, the Company was able to identify and verify trends in the Company’s claims data which indicated that the Company’s claims experience was stabilizing, becoming less volatile, and becoming consistently related to industry trends in the tort system generally, which led to the Company’s belief that extrapolation from its past claims experience could, for the first time, form the basis for a reasonable estimate of potential future claims, the Company’s handling and processing of asbestos-related claims (as noted by the Staff in the May 11 letter) collectively improved the quantity and quality of information available to the Company respecting those claims, which in turn increased the real-time visibility to the Company and its senior professionals regarding the handling and resolution of individual asbestos-related claims. This information has been used by the Company in its litigation and settlement efforts to determine better how to resolve individual claims, resulting in more consistent litigation and settlement efforts respecting asbestos claims as a whole and more stable settlement and defense costs, changes implemented by courts in certain jurisdictions in which the Company is most often named as a defendant in asbestos-related litigation, which were incorporated into the Company’s litigation and settlement efforts, allowing for greater litigation and settlement consistency and predictability in the Company’s claims projections, co-defendant bankruptcies and the magnitude and timing of bankruptcy trust payments to claimants became more consistent, and information as to both was increasingly required to be made available by claimants, which affected the value of claims asserted against the Company, and the number of asbestos-related claims faced by the Company was significantly reduced as a result of the Company’s ongoing efforts to eliminate many claims that had become dormant as a result of the passage of time or otherwise capable of being dismissed, which allowed the Company greater ability to forecast outcomes respecting potential claims not yet asserted.

The culmination of all of the foregoing factors in 2016 led the Company to consider, as part of its ongoing review process, that it had become possible to make a reasonable estimate of its potential liability for asbestos-related claims not yet asserted. The Company engaged a third-party consultant in the third quarter of 2016, as the Staff notes in the May 11 letter, to assist the Company with its evaluation of such potential liability. The consultant prepared its analysis during the third and fourth quarters of 2016, and presented its final analysis to the Company in the first quarter of 2017. The Company reviewed the analysis and made its own assessment in connection with the Company’s preparation of its annual financial statements for 2016 that the best estimate of the aggregate liability both for asbestos-related claims asserted but not yet resolved and potential asbestos-related claims not yet asserted, including an estimate for defense costs, was $879.3 million, and adjusted its liability on its consolidated balance sheet in accordance with ASC 450-20-25-2.

The Company does not consider this additional reserve to be a correction of an error in prior financial statements because no error was made. There were no mistakes in the application of GAAP, mathematical errors or oversight or misuse of facts in previously issued financial statements. The Company was diligent in its efforts to monitor and track available information to measure the potential liability for future asbestos-related claims, and appropriately recorded a reserve when information sufficient to support a reasonable estimate became available. The Company followed generally accepted accounting principles - specifically, ASC 450-20-25-2 - in only accruing a liability once such amount was capable of being reasonably estimated.

Read in the reply
In its next report

First report after the company's reply of May 25, 2017: 10-Q filed Jul 27, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (1)
We note your response that you concluded your revised estimate for asbestos-related claims is a change in accounting estimate rather than a correction of an error in previously issued financial statements because the quarter ending December 31, 2016 is the first time that the liability attributable to potential asbestos-related claims not yet asserted could be reasonably estimated.
Rest of the question

You state that prior to the quarter ending December 31, 2016, you concluded claims data was too volatile, and the circumstances in which future asbestos-related claims would be resolved too uncertain, to support a reasonable estimate of the liability for potential claims not yet asserted. Based on your response, it appears you believed a liability for potential claims not asserted was probable prior to the quarter ending December 31, 2016, but that such liability was not recognized because it could not be reasonably estimated. Please confirm whether our understanding is correct. Regarding periods prior to the quarter ending December 31, 2016, please tell us whether you (1) attempted to estimate a liability for potential claims but concluded the resulting estimate of loss (or range) was not reasonable or (2) did not attempt to estimate a liability because you believed you could not develop a reasonable estimate. If the former, please tell us the results of your estimation including your estimated liability (or range thereof) as of December 31, 2015 and why you did not believe the estimate(s) to be reasonable.

BWA answered
a.

We confirm the Staff’s understanding is correct with respect to the first request herein.

b.

With respect to the Staff’s second request herein, we confirm that the latter statement is correct. The Company did not attempt to estimate a liability for such periods because a reasonable estimate could not be made.
Read in the reply
In its next report

First report after the company's reply of Jul 10, 2017: 10-Q filed Jul 27, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (2)
Please provide us a more comprehensive and specific explanation of how you determine the amount of asbestos-related costs you recorded each period. Tell us the most significant assumptions underlying your asbestos-related liability, including the impact of and reasons for changes in those assumptions during each period presented.
BWA answered
The Company estimates two types of asbestos-related claims: asbestos-related claims asserted but not yet resolved, and asbestos-related claims not yet asserted. In each case, the Company’s estimates are based upon the Company’s claims data and claims handling experience. The Company has controls and processes in place to monitor and review incoming claims and the resolution of claims through dismissals and settlements so as to keep the Company’s information as to claims that have been resolved, and those that have been asserted but not yet resolved, continually updated.
Rest of the answer

The Company also reviews its claims data and claims handling experience to evaluate, as detailed in the May 25 Letter, whether a reasonable estimate may be made of asbestos-related claims asserted but not yet resolved and asbestos-related claims not yet asserted.

With respect to asbestos-related claims asserted but not yet resolved, the Company determines the estimated amount of liability, as well as estimated associated defense costs, by determining an estimated level of settlements that will result from the population of claims filed against the Company. Specifically, the Company applies assumptions to this claims population, based on its claims experience, as to:

• the percentage of such claims that are likely to result in a payment;

the average settlement value for claims that are assumed to result in a payment; and the amount of defense costs applicable to such claims.

The underlying assumptions used to estimate the liability for asbestos-related claims asserted against the Company but not yet resolved did not change significantly in the periods presented in the Form 10-K.

With respect to asbestos-related claims not yet asserted, as described in further detail in the May 25 Letter, for periods prior to 2016, the Company concluded that its claims data was too volatile, and the circumstances in which future asbestos-related claims would be resolved too uncertain, to support a reasonable estimate of the liability for potential asbestos-related claims not yet asserted based on the facts known to the Company at that time. The Company determined following its re-evaluation in the third quarter of 2016, based on a culmination of factors including the verification of trends in its own claims data, that it was able to determine for the first time that its potential liability for asbestos-related claims not yet asserted was capable of reasonable estimation.

To arrive at that estimation, the Company engaged a third-party consultant specializing in the actuarial modeling and valuing of future asbestos-related claims. The Company, with the assistance of the consultant, then utilized information from its analysis of its prior claims experience, data and information respecting its claims history, and data and information respecting claims then pending against the Company to estimate the number of claims that may be asserted against the Company in the future. The projected number and types of potential asbestos-related claims that may be asserted against the Company in the future were then extrapolated over time by using anticipated levels of asbestos-related disease in the overall U.S. population, as estimated by an epidemiological model based on past claims data from the U.S. tort system involving all defendants and modified to take account of updates in recent years. This model covers the full remaining period in which such claims are likely to be asserted, which the Company estimated (based on current standard industry models) would be through December 31, 2059. Using the Company’s recent claims experience against this model, the third party consultant developed a Company-specific model for the number and types of asbestos-related claims that may be asserted against the Company through December 31, 2059. Assumptions were then applied to this Company-specific model as to the percentages of such claims that may be resolved with payment, the average costs to resolve such claims, and the aggregate defense costs applicable to such claims. This created an aggregate estimate of the value of potential asbestos-related claims that may be asserted against the Company in the future.

As a result of the above estimates and the ability to reasonably estimate its potential liability for asbestos-related claims not yet asserted for the first time in connection with the Company’s preparation of its annual financial statements for 2016, the Company recorded an increase to its estimate of the aggregate liability both for asbestos-related claims asserted but not yet resolved and potential asbestos-related claims not yet asserted, including an estimate for defense costs, of $770.8 million.

The Company necessarily made a number of assumptions in arriving at the estimate of its potential liability for asbestos-related claims not yet asserted. The most significant of those assumptions are, in no particular order:

the percentage of asbestos-related claims asserted industry-wide in which BorgWarner Morse TEC LLC (the applicable subsidiary of BorgWarner Inc.) (“Morse TEC”) is named will be consistent with the Company’s claims experience in recent years;

the percentage of asbestos-related claims asserted against Morse TEC that result in a payment will be consistent with the Company’s claims experience in recent years;

the average cost of resolving asbestos-related claims against Morse TEC will be consistent with the Company’s claims experience in recent years;

the mix of asbestos-related disease types (e.g., mesothelioma, lung cancer, non-malignant conditions) in claims asserted against Morse TEC will be consistent with its claims experience in recent years, with mesothelioma claims comprising a large majority of Morse TEC’s expenditures on account of asbestos-related claims;

the defense costs incurred by Morse TEC in connection with asbestos-related claims will decline over time in proportion to the decline in the number of such claims; and assumptions respecting the management and defense of asbestos-related claims asserted against Morse TEC in the jurisdictions in which the largest number of claims are asserted against Morse TEC.

A number of significant industry-wide assumptions were also employed in the development of this estimate, including (in no particular order):

that the U.S. tort system will remain relatively consistent with its status as of December 31, 2016 (e.g., no material legislative or judicial changes affecting the bringing or resolution of asbestos-related claims);

the diagnosis and treatment of asbestos-related diseases will continue substantially as they were at December 31, 2016; and claims will continue to be asserted against Morse TEC and other defendants in the U.S. tort system through December 31, 2059, with a runoff period for the resolution of such claims through December 31, 2067.

None of the above factors predominates in calculating the estimate, and the impact of changes to any of such factors - whether to reduce or increase the potential liability - is inherently uncertain, based on the reasons for any such change, secondary effects thereof, and the magnitude of such change.

Read in the reply
In its next report

First report after the company's reply of Jul 10, 2017: 10-Q filed Jul 27, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (3)
We note your disclosure that any amounts that are reasonably possible of occurring in excess of amounts recorded are believed to not be significant. We also note your disclosure that your best estimate of liability at December 31, 2016 was $879.3 million and that such amount represents the actuarial central estimate, which is intended to represent an expected value of the most probable outcome.
Rest of the question

Please tell us what you determined to be the range of reasonably possible outcomes. In light of your claims experience, please tell us how you considered ASC 450-20-50-3 and 50-4 regarding disclosing a range of reasonably possible losses in excess of your asbestos-related accrual.

BWA answered
The Company determined that the upper end of the range of reasonably possible outcomes respecting its estimated asbestos-related liabilities was $983.5 million. As noted in the June 23 letter, the Company concluded as part of its estimation process that the actuarial central estimate within the range of estimated liabilities it determined - $879.3 million - was the best estimate of its potential liability for asbestos claims not yet resolved (both asserted and unasserted).
Rest of the answer

The Company accordingly used that figure as the basis for the estimated liability recorded on its 2016 balance sheet in accordance with ASC 450-20-30-1, which provides that “[i]f some amount within a range of loss appears at the time to be a better estimate than any other amount within that range, that amount shall be accrued.”

The Company has not disclosed a potential range of loss in excess of the amount already accrued under ASC 450-20-50-3 and 50-4 because the amount of such additional potential loss considered reasonably possible is not significant, and hence disclosure thereof is not required for the financial statements not to be misleading, as discussed in ASC 450-20-50-1 and SAB Topic 5Y. The difference between the amount of the upper end of the range of reasonably possible outcomes respecting the Company’s estimated asbestos-related liabilities ($983.5 million) and the amount of the estimated liability actually accrued in the Company’s financial statements ($879.3 million) is $104.2 million. The Company does not believe that disclosure of such potential additional losses is material to the Company’s consolidated financial statements and, given the long-term nature of the estimate and the uncertainty of the assumptions, is not useful or beneficial to the users of the financial statements.

Read in the reply
In its next report

First report after the company's reply of Jul 10, 2017: 10-Q filed Jul 27, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (4)
Please tell us why decided to hire the third-party consultant in the third quarter of 2016 and whether you had previously hired consultants for such work.
BWA answered
The Company retained the third-party consultant to provide specialized actuarial assistance in connection with the estimation of its asbestos-related claims asserted but not yet resolved and those not yet asserted. The Company’s in-house personnel have extensive experience with issues respecting asbestos-related claims, including, for example, in analyzing the Company’s asbestos claims information, identifying trends in the Company’s claims experience, and estimating the aggregate costs to be incurred on account of asbestos-related claims asserted but not yet resolved.
Rest of the answer

The Company determined, however, that it required additional actuarial expertise specific to the estimation and modeling of asbestos-related liabilities over significant future periods (i.e., approximately 50 years) in order to conduct an estimation of its asbestos-related claims not yet asserted that could be reasonable for U.S. GAAP purposes. Such expertise included the ability to create a reliable model of the incidence of asbestos-related disease in the U.S. population generally over the expected claiming period, and then to perform the necessary comparison of the projected number of potential asbestos-related claims that may be asserted against the Company to such model in order to create an aggregate estimate of the value of potential asbestos-related claims that may be asserted against the Company in the future.

The Company accordingly retained the third-party consultant in the third quarter of 2016 following a determination by the Company that its potential liability for asbestos-related claims not yet asserted may be capable of reasonable estimation. The Company reached that conclusion at that time for the several reasons set forth on pages 3 and 4 of the May 25 Letter.

The Company did not retain consultants for the purpose of establishing or evaluating liability estimates for financial reporting purposes prior to the third quarter of 2016.

Read in the reply
In its next report

First report after the company's reply of Jul 10, 2017: 10-Q filed Jul 27, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (5)
Please quantify for us the amount of the liability at December 31, 2016 that relates to potential claims not yet asserted.
BWA answered
The estimated amount of the liability that relates to potential claims not yet asserted and their associated defense costs at December 31, 2016 is $787.4 million.
Read in the reply
In its next report

First report after the company's reply of Jul 10, 2017: 10-Q filed Jul 27, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (1)
We note your response to our prior comment 1 that you concluded a liability for potential claims not asserted was probable prior to the quarter ending December 31, 2016 but you did not attempt to estimate a liability because you concluded you could not develop a reasonable estimate.
Rest of the question

In your response to our prior comment 4 you state that you retained the third-party consultant to provide specialized actuarial assistance in connection with the estimation of your asbestos- related claims asserted but not yet resolved and those not yet asserted. You state your inhouse personnel have experience with issues respecting asbestos-related claims, including, for example, in analyzing your asbestos claims information, identifying trends in your claims experience, and estimating the aggregate costs to be incurred on account of asbestos-related claims asserted but not yet resolved. You determined, however, that you required additional actuarial expertise specific to the estimation and modeling of asbestos-related liabilities over significant future periods (i.e., approximately 50 years) in order to conduct an estimation of your asbestos-related claims not yet asserted. Such expertise included the ability to create a reliable model of the incidence of asbestosrelated disease in the U.S. population generally over the expected claiming period, and then to obtain the projected number of potential asbestos-related claims that may be asserted against you resulting from such model in order to create an aggregate estimate of the value of potential asbestos-related claims that may be asserted against you in the future. It continues to be unclear why you did not retain a third-party consultant prior to third quarter of 2016 to provide that specialized actuarial assistance in connection with the estimation of your asbestos-related claims asserted but not yet resolved and those not yet asserted. Paragraph 450-20-25-5 states that accrual of a probable loss should not be delayed until only a single amount can be reasonably estimated. To the contrary, when a loss is probable and information available indicates that the estimated amount of loss is within a range of amounts, it follows that some amount of loss has occurred and can be reasonably estimated. Thus, when a loss is probable and the reasonable estimate of the loss is a range, an amount should be accrued for the loss. Paragraph 450-20-30-1 states if some amount within a range of loss appears to be a better estimate than any other amount within the range, that amount shall be accrued. When no amount within the range is a better estimate than any other amount, however, the minimum amount in the range should be accrued. Therefore, your basis for limiting your ASC 450 assessment to asbestos-related claims asserted but not yet resolved continues to be unclear. An ASC 450 assessment should consider all claims both asserted but not yet resolved and claims not yet asserted. Based on your assertion that losses for claims not yet asserted were probable (i.e., not zero), it appears that the conditions to record a liability would be met for at least a minimum amount within a range. Therefore, please address the following: Your disclosure states that “the Company has made enhancements to the management and analysis of asbestos-related claims, including specifically: the engagement of new National Coordinating Counsel with significant asbestos litigation experience and a global presence, the engagement of several new local counsel panels; outsourcing administration and claims handling to a third party; implementing various improvements in the processing of asbestosrelated claims so as to allow the Company’s management to have greater real-time insight into the handling of individual asbestos-related claims; and increasing audits and compliance reviews of counsel handling asbestos-related claims. This process has as of the end of 2016 resulted in improvements in both the quantity and the quality of the information available to the Company’s management respecting individual asbestos-related claims and their handling and disposition. This process has also resulted, in the Company’s view, in an increased ability to reasonably forecast the aggregate number of potential future asbestos-related claims that may be asserted against the Company.” a) Please explain in what ways the enhancements improved both the quantity and quality of the information available to management. b) Compare the quality and quantity of the information available to management before and after the company’s enhancements and why there were differences. c) Please explain why you undertook to implement those enhancements and why they were implemented at that time.

BWA answered
to our prior comment 4 you state that you retained the third-party consultant to provide specialized actuarial assistance in connection with the estimation of your asbestosrelated claims asserted but not yet resolved and those not yet asserted. You state your in-house personnel have experience with issues respecting asbestos-related claims, including, for example, in analyzing your asbestos claims information, identifying trends in your claims experience, and estimating the aggregate costs to be incurred on account of asbestos-related claims asserted but not yet resolved.
Rest of the answer

You determined, however, that you required additional actuarial expertise specific to the estimation and modeling of asbestos-related liabilities over significant future periods (i.e., approximately 50 years) in order to conduct an estimation of your asbestos-related claims not yet asserted.

Such expertise included the ability to create a reliable model of the incidence of asbestos-related disease in the U.S. population generally over the expected claiming period, and then to obtain the projected number of potential asbestos-related claims that may be asserted against you resulting from such model in order to create an aggregate estimate of the value of potential asbestos-related claims that may be asserted against you in the future. It continues to be unclear why you did not retain a third-party consultant prior to third quarter of 2016 to provide that specialized actuarial assistance in connection with the estimation of your asbestos-related claims asserted but not yet resolved and those not yet asserted.

Paragraph 450-20-25-5 states that accrual of a probable loss should not be delayed until only a single amount can be reasonably estimated. To the contrary, when a loss is probable and information available indicates that the estimated amount of loss is within a range of amounts, it follows that some amount of loss has occurred and can be reasonably estimated. Thus, when a loss is probable and the reasonable estimate of the loss is a range, an amount should be accrued for the loss.

Paragraph 450-20-30-1 states if some amount within a range of loss appears to be a better estimate than any other amount within the range, that amount shall be accrued. When no amount within the range is a better estimate than any other amount, however, the minimum amount in the range should be accrued.

BW 921-0003

Therefore, your basis for limiting your ASC 450 assessment to asbestos-related claims asserted but not yet resolved continues to be unclear.

An ASC 450 assessment should consider all claims both asserted but not yet resolved and claims not yet asserted. Based on your assertion that losses for claims not yet asserted were probable (i.e., not zero), it appears that the conditions to record a liability would be met for at least a minimum amount within a range. Therefore, please address the following:

Your disclosure states that “the Company has made enhancements to the management and analysis of asbestos-related claims, including specifically: the engagement of new National Coordinating Counsel with significant asbestos litigation experience and a global presence, the engagement of several new local counsel panels; outsourcing administration and claims handling to a third party; implementing various improvements in the processing of asbestos-related claims so as to allow the Company’s management to have greater real-time insight into the handling of individual asbestos-related claims; and increasing audits and compliance reviews of counsel handling asbestos-related claims. This process has as of the end of 2016 resulted in improvements in both the quantity and the quality of the information available to the Company’s management respecting individual asbestos-related claims and their handling and disposition. This process has also resulted, in the Company’s view, in an increased ability to reasonably forecast the aggregate number of potential future asbestos-related claims that may be asserted against the Company.” a) Please explain in what ways the enhancements improved both the quantity and quality of the information available to management.

b) Compare the quality and quantity of the information available to management before and after the company’s enhancements and why there were differences.

c) Please explain why you undertook to implement those enhancements and why they were implemented at that time.

RESPONSE:

We address each of comments 1(a) through 1(c) in turn below. We also address as an initial matter the Staff’s comment that “[i]t continues to be unclear why you did not retain a third-party consultant prior to third quarter of 2016 to provide that specialized actuarial assistance in connection with the estimation of your asbestos-related claims asserted but not yet resolved and those not yet asserted.” The Company did not retain a third-party consultant prior to the third quarter of 2016 because the Company did not believe prior to that time that a reasonable estimate of its liability for potential asbestos-related claims not yet asserted could be made. The reasons for that determination, and the Company’s determination that a reasonable estimate of such claims could be made in 2016, are set forth in the response to comment #7, below. The Company also addresses the Staff’s comment above that “your basis for limiting your ASC 450 assessment to asbestos-related claims asserted but not yet resolved continues to be unclear” in the response to comment #7, below.

BW 921-0004 a)

Enhancements in the management and analysis of asbestos-related claims have improved the quantity and quality1 of the information available respecting individual asbestos-related claims and their handling and disposition. The enhancements referred to in the disclosure are a by-product of the Company’s overall shift in defense strategy and claims resolution in the past few years.

[CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.] The Company has modified its defense strategy over time as external factors described further below have impacted the number, types, and quality of claims against the Company.

[CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.]

_________________________

1. The Company has always used the best information available to it for conducting both the defense and evaluation of asbestos-related claims and for evaluating whether its claims experience could be projected into the future as one element of making a reasonable estimation of asbestos-related claims not yet asserted in accordance with ASC 450. The Company sees, based on the Staff’s comments and discussions with the Staff, that the reference to improvements in the “quality” of information contained in the disclosure could be clarified. The Company accordingly proposes to change references to the “quality” of information to “types” of information in any future disclosures containing this language.

BW 921-0005

Particular aspects of the Company’s new defense strategy have also impacted the quantity and types of information available to the Company respecting asbestos-related claims as follows:

Enhancement

Results

BW 921-0006

Retention of new National Coordinating Counsel and engagement of new local counsel panels.

In the execution of the new litigation strategy, the Company’s new counsel have been integral in allowing the Company to conduct greater levels of discovery respecting asbestos-related claims (resulting in more information respecting individual claims) on an efficient and cost-effective basis.

Outsourcing administration and claims handling to a third-party with extensive experience in handling asbestos-related claims, implementing various improvements in the processing of asbestos-related claims, and performing increased audits and compliance reviews of counsel handling asbestos-related claims.

The Company is better able to perform real-time review of pending asbestos-related claims as a result of technological improvements, which allow more consistent decisions regarding defense and settlement or litigation of individual claims. The Company utilizes this information to perform more audits and compliance reviews of counsel handling asbestos-related claims to ensure consistent execution of its litigation and defense strategy.

These enhancements, in turn, contribute to more stable, consistent claims resolutions, with resulting increases in the stability and consistency of the Company’s claims data over time.

b)

The quantity and types of information available to management in executing its litigation and defense strategy with respect to asbestos-related claims have been impacted by the specific changes as discussed above, [CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.].

[CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.], the Company has always used the best available information for conducting both the defense and valuation of asbestos-related claims and for evaluating whether its claims experience could be projected into the future as one element of making a reasonable estimation of asbestos-related claims not yet asserted in accordance with ASC 450. As mentioned above, the set of data fields used by the Company for defense purposes and for preparing its financial statements, including with respect to ASC 450 compliance, has always been the same. Furthermore, the Company has had controls in place regarding the completeness and accuracy of the underlying data used in the ASC 450 assessments both before and after the changes discussed above.

BW 921-0007 c)

The Company undertook these enhancements in recent years due to the changes in external factors in the asbestos litigation environment and adaptation of its defense strategy to these factors, as described in the response to question 1(a).

Read in the reply
In its next report

First report after the company's reply of Sep 21, 2017: 10-Q filed Oct 26, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (2)
We note your disclosure that “The comparatively large number of claims resolved in 2015 reflected the Company’s efforts to dismiss large numbers of inactive or otherwise unmeritorious claims in order to be better positioned to evaluate remaining and future claims, while the smaller number of total claims resolved in 2016 reflects in part the outcome of those efforts.” We also note your disclosure that “in recent
Rest of the question

years, the Company has made enhancements to the management and analysis of asbestos-related claims” and that “this process has also resulted, in the Company’s view, in an increased ability to reasonably forecast the aggregate number of potential future asbestos-related claims that may be asserted against the Company.” a) Please tell us in detail the nature of the “enhancements to the management and analysis of asbestos-related claims” that you made and indicate the extent to the procedures the company undertook prior to the enhancements to the management and analysis of asbestos-related claims differed. b) Please describe the nature of the efforts the Company undertook that resulted in the “comparatively larger number of claims resolved in 2015.” c) Please explain why you undertook these efforts and what prompted you to undertake those efforts at that time. d) We note your disclosure that appears to state that you undertook these efforts “to be better positioned to evaluate remaining and future claims”. Please tell us whether or not the efforts you took to dismiss large numbers of inactive or otherwise unmeritorious claims that resulted in you being in a better position to evaluate remaining and future claims also provided you with a better position to determine a reliable estimate of your unasserted asbestos claims. e) Please explain to us how you obtained information about existing and future claims prior to the efforts that resulted in the claims being resolved in 2015.

BWA answered
The enhancements to the management and analysis of asbestos-related claims referred to by the Company in the July 10 Letter, and a comparison to the procedures followed previously, are described in the answer to comment #1 above and are incorporated here by reference.

As stated, these enhancements were made as part of the change in the Company’s litigation and defense strategy in reaction to the external factors discussed in the response to comment #1 above.
Rest of the answer

The Company’s process with respect to its ASC 450 analysis was the same before and after the enhancements to its litigation and defense strategy. While the data attributes reviewed by the Company in determining if a reasonable estimate of the number of potential asbestos-related claims not yet asserted could be made did not change, the changes to the litigation and defense strategy

BW 921-0008 impacted the underlying information used in the Company’s ASC 450 assessment [CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.].

The nature of the efforts undertaken by the Company included the identification of dormant claims or claims not otherwise prosecuted that had potential to be dismissed and where motions to dismiss would likely be successful [CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.].

It is common for asbestos plaintiffs to name numerous defendants in their claims and then, for a variety of reasons, decide not to prosecute the claim, prosecute the claim only as to certain defendants, or delay prosecuting the claim as to some or all defendants. A defendant against whom a claim is asserted but not prosecuted may seek to dismiss that claim after a period of time [CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.].

The Company continually reviews pending claims to identify any potentially dormant claims in which a dismissal may be possible. [CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.]. Based on claims filing patterns and the passage of time, the Company often experiences periods of increased dismissal activity. [CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.]

[CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.] These efforts resulted in a reduction in the number of pending claims by 48% over the past few years as disclosed in the Company’s 10-K. The reference to the “comparatively large number of claims resolved in 2015” is in comparison to 2016, reflecting the year-over-year change in the number of dismissals.

As discussed above, a defendant against whom a claim is asserted but not prosecuted may seek to dismiss that claim after a period of time

[CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.].

BW 921-0009 d)

The Company routinely reviews pending claims for potential dismissal opportunities. It believes that the reduction in the number of asbestos-related claims that resulted from its efforts to dismiss dormant claims or claims not otherwise prosecuted, gave it the ability to redeploy defense resources [CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.]. The Company believes that this is one of the factors that contributed to a claims population that is more stable and more likely to form the basis for a reasonable estimate of potential asbestos-related claims not yet asserted.

e)

The Company continues to obtain information respecting existing claims from the complaint filed by the claimant, discovery from the claimant, and negotiations with the claimant’s counsel. Information obtained respecting existing claims is presently stored within a database maintained by the third-party claims handling administrator.

Prior to outsourcing administration and claims handling, these processes were performed internally, with similar data fields and documentation being retained within an internal database. Controls have been in place consistently over the completeness and accuracy of the data points used in the Company’s ASC 450 assessment contained in both the internally maintained database and the database maintained by the outsourced third-party claims handling administrator. This information forms the basis of the quantitative inputs in the Company’s ASC 450 assessment as to whether a reasonable estimate of the liability for potential asbestos-related claims not yet asserted can be made.

Similar information on potential asbestos-related claims not yet asserted was not available in prior years as those claims have not yet been asserted by definition. Instead, the Company has always made assumptions respecting claims not yet asserted in order to determine if it could reasonably estimate the liability for such claims. The assumptions used are described in the July 10 Letter (see response to comment #2).

Read in the reply
In its next report

First report after the company's reply of Sep 21, 2017: 10-Q filed Oct 26, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (3)
We note your disclosure that “Legislative and judicial developments affecting the U.S. tort system generally, including medical criteria legislation, procedural reforms, and docket control measures relating to so-called unimpaired claims, have also stabilized certain aspects of the Company’s defense efforts respecting asbestos-related claims and allowed the Company greater insight into the number and value of
Rest of the question

potential future claims in recent years.” Please tell us when these developments took place and tell of the period of time you refer to as “in recent years.”

BWA answered
BW 921-00010

Although tort reforms such as those identified by the Company in its disclosure have been ongoing in various states throughout the history of asbestos litigation in the United States, the legislative and judicial developments referred to in the Company’s disclosure took place at various points over roughly the past ten years.
Rest of the answer

Given the pace of asbestos litigation, the number of jurisdictions involved, and the time it takes for many state-wide tort reforms to be interpreted and implemented, it has taken until roughly the last three years [CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.]. That roughly-three-year period is the “in recent years” period referred to in the Company’s disclosure.

The reforms described by the Company in the disclosure and referred to by the Staff in the August 23 Letter have in general had long-term effects on claiming patterns against the Company that are inherently difficult to predict.

Relatively few states have adopted state-wide tort reforms over the past five to seven years. This has allowed time for those reforms to be interpreted and consistently applied by courts in the relevant jurisdictions and has also allowed time for shifts in the jurisdictions in which asbestos claims are asserted to occur and for the Company to develop claims histories in various “new” jurisdictions. [CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.] Moreover, where recent tort reforms have occurred and had an immediate impact, they have been at the individual trial court level, where they require less time to implement, and their effects can more quickly be projected.

Read in the reply
In its next report

First report after the company's reply of Sep 21, 2017: 10-Q filed Oct 26, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (4)
We note your disclosure that a third party consultant was hired in the third quarter of 2016 and that the “consultant’s work utilized the updated data and analysis resulting from the Company’s claim review process”. Please explain to us what you mean when you refer to “updated data”.
Rest of the question

Please clarify in your response whether or not the “updated data” included information that was used by the company in its management and analysis of asbestos-related claims prior to implementing the enhancements.”

BWA answered
The Company’s reference to “updated data” is to its claims data that has, by definition, evolved based on the most current facts and circumstances respecting individual asbestos claims, changes occurring in the asbestos litigation landscape and impacts of other relevant factors, including facts developed about specific claims through its updated litigation and defense strategy discussed in the response to comment #1.

The Company’s claims data is contained in a live database that is updated on a regular basis.
Rest of the answer

The completeness and accuracy of the key data attributes utilized in the Company’s ASC 450 analysis are reviewed and tested under the Company’s internal control process on an ongoing basis. Additions to the Company’s claims data, including new claims filings and updates to existing claims, claims resolutions (such as settlements or dismissals) or information developed through the claims negotiation, discovery, and litigation processes

[CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.], are made continually. To avoid any potential doubt, updates are not made with respect to claims after they are settled or dismissed (other than to incorporate settlement data or the fact of the dismissal), since those claims are by definition no longer being asserted against the Company and require no defense efforts or expenditures.

As described in the Company’s disclosure, the claims data described above was used by the third-party consultant in preparing its estimate of potential claims not yet asserted. In addition, the Company considers, and has in the past considered, the data during management’s internal control process as one part of its determination whether a reasonable estimate of the liability for potential asbestos-related claims not yet asserted is possible under ASC 450.

Read in the reply
In its next report

First report after the company's reply of Sep 21, 2017: 10-Q filed Oct 26, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (5)
We note your disclosure that “In developing the estimate of liability for potential future claims, the third-party consultant projected a potential number of future claims based on the Company’s historical claim filings and patterns and compared that to anticipated levels of unique plaintiff asbestos-related claims asserted in the U.S. tort system against all defendants.
Rest of the question

The consultant also utilized assumptions based on the Company’s historical proportion of claims resolved without payment, historical settlement costs for those claims that result in a payment, and historical defense costs. The liabilities were then estimated by multiplying the pending and projected future claim filings by projected payments rates and average settlement amounts and then adding an estimate for defense costs.” Please explain to us why historical data was used when it was previously considered unreliable. Also clarify whether or not the historical data was updated as a result of the enhancements the Company made to its management and analysis of asbestos-related claims.

BWA answered
Historical data was used because it is standard practice to estimate a defendant’s liability for potential asbestos-related claims not yet asserted by extrapolating the defendant’s claims history into the future. The previous data was not considered to be unreliable, but rather too volatile and unpredictable to support a reasonable estimate of liability for potential asbestos-related claims not yet asserted when taken together with other factors affecting the reasonable estimability of such claims (which are discussed in detail in the disclosure and in the response to comment #7, below).

The
Rest of the answer

2016 estimate prepared by the third-party consultant used a 2.75 year calibration (or “look-back”) period; that is, it was based upon an extrapolation from the Company’s most recent 2.75 years of claims experience.

[CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.]. The relatively short-term calibration period also reflects the recent asbestos litigation landscape [CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.].

The information used by management in its assessment of its potential future liabilities before and after the enhancements has been the same. The Company has controls in place regarding the completeness and accuracy of the underlying data used in the ASC 450 evaluation process before and after the changes discussed above.

Read in the reply
In its next report

First report after the company's reply of Sep 21, 2017: 10-Q filed Oct 26, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (6)
Please provide us with a schedule that identifies the following for each annual period from 2005 to 2016. a) Number of claims filed b) Number of claims settled c) Number of claims dismissed d) Number of claims outstanding at the beginning and end of the period e) Asbestos liability asserted claims at the beginning of the period f) Asbestos liability accrued for asserted claims g) Asbestos liability asserted at the
Rest of the question

end of the period h) Asbestos liability unasserted claims at the beginning of the period i) Asbestos liability accrued for unasserted claims

BWA answered
Please refer to Exhibit A for the specific data points requested above.
Read in the reply
In its next report

First report after the company's reply of Sep 21, 2017: 10-Q filed Oct 26, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

n) Insurance proceeds received · o) Defense costs associated with asbestos related claims
SEC asked (7)
We note your disclosure that “The inability to arrive at a reasonable estimate of the liability for potential asbestos-related claims that may be asserted in the future was based on, among other factors, the volatility in the number and type of asbestos claims that may be asserted, changes in asbestos-related litigation in the United States, the significant number of codefendants that have filed for bankruptcy, the
Rest of the question

magnitude and timing of co-defendant bankruptcy trust payments, the inherent uncertainty of future disease incidence and claiming patterns against the Company, and the impact of tort reform legislation that may be enacted at the state or federal levels.” Please explain why these factors caused you to be unable to arrive at a reasonable estimate of unasserted asbestos-related claims in prior periods but did not cause you to be unable to arrive at a reasonable estimate of unasserted asbestos-related claims in 2016. We note your disclosure on page 97 that the 2016 estimate of unasserted asbestos-related claims “is based on currently available information and assumptions that the Company believes are reasonable.”

BWA answered
The Company’s consideration of these factors began with ASC 450-20-25-2’s requirement that the Company conclude that a loss relating to potential future asbestos-related claims not yet asserted is both probable and capable of being reasonably estimated in order for the loss to be accrued. ASC 450-20-25-4 provides further that the requirement for reasonable estimability of a loss is “intended to prevent accrual in the financial statements of amounts so uncertain as to impair the integrity of those statements.” As the Staff notes in comment #1 of the August 23 Letter, although accrual of a loss
Rest of the answer

may not be delayed until the estimate of a loss is reduced to a single number, ASC 450-20-25-5 requires both that a loss is probable and that “the reasonable estimate of the loss is a range” in order for accrual to occur. If no reasonable estimate of a

BW 921-00014 particular loss can be made (either at a single number or a range), then ASC 450-20-25-2 and 450-20-50-5 provide that “[d]isclosure is preferable to accrual…”

For periods prior to 2016, the Company concluded that a reasonable estimate of loss could not have been made (either at a single number or range) and provided disclosure in lieu of accrual as directed by ASC 450-20-50-5. The Company identified in its disclosure several factors supporting that conclusion. Those factors were:

•

[CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.];

the volatility in claim filing patterns against the Company, including the number and type of asbestos-related claims asserted against it, which resulted in its claims history showing neither trends sufficiently consistent to give rise to a reasonable estimate (that is, trends that could be reasonably extrapolated into the future) nor sufficient correlation when compared to industry-wide asbestos claiming patterns to suggest that such claiming patterns might allow a reasonable projection of future claims against the Company;

the significant number of co-defendants that filed for bankruptcy, which reduced the number of co-defendants on an average claim by more than 30 as those defendants stopped defending asbestos-related claims due to the stay of claims against them imposed by their bankruptcies;

the magnitude and timing of co-defendant bankruptcy trust payments, which became increasingly significant over the last five to ten years as more bankruptcy trusts began making payments to plaintiffs [CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.]; and inherent uncertainty in attempting to predict the number and type of claims that might be asserted against the Company in the future, [CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 CFR 200.83.].

All of those factors collectively formed the basis for the Company’s conclusion in prior periods that a reasonable estimate of its potential asbestos-related claims not yet asserted could not be made. Although the Company had concluded in prior periods that it was probable that additional asbestos-related claims may be asserted against it in the future, and the Company disclosed that conclusion at the time, the uncertainty resulting from the combination of all the foregoing variables would have made any estimate of

BW 921-00015 the Company’s potential asbestos-related claims not then asserted - including a range of amounts for such claims not reasonable and inherently speculative. Because a reasonable estimate of the Company’s potential asbestos-related claims not yet asserted was not possible - either as a single amount or as a range - the Company followed the guidance in ASC 450-20-25-2 and 450-20-50-5 that “disclosure is preferable to accrual” rather than adopting an artificial, unreasonable “floor” as an estimate, which would have tended to impair the integrity of the Company’s financial statements, which is precisely the outcome ASC 450-20-25-4 is intended to prevent.

The Company re-evaluated those factors in connection with the preparation of its annual financial statements for 2016, as it had for prior periods. The Company concluded based on that re-evaluation that its potential liability for asbestos-related claims not yet asserted was capable of reasonable estimation for several reasons:

the Company was able in 2016 to identify and verify trends in its claims data for recent years which indicated that the specific claims experience was becoming less volatile and was stabilizing, while also becoming more consistently related to industry-wide asbestos claims data, which led it to believe that it was more likely that a reasonable estimate could be extrapolated from the Company’s recent claims data;

co-defendant bankruptcies slowed to historically low levels;

significant asbestos trusts began making payments in recent years and the effect of those payments on the proportionate liability of defendants not in bankruptcy (such as the Company) began to be seen; and the inherent uncertainty in attempting to reasonably estimate future claims was partially reduced as a result of the elimination of many dormant claims and other actions in the Company’s strategy for defending and resolving asbestos-related claims (as detailed in the response to comment #2 above).

As was the case for prior periods, the changes to the external factors described above were interdependent, and changes to no one factor or subset of factors were determinative or represented a single triggering event that would have made a reasonable estimate of potential asbestos-related claims not yet asserted possible. The Company reviewed the developments in its own claims history and in the tort system as a whole, and that review led the Company to consider that it might be possible to make a reasonable estimate of potential liability for asbestos-related claims not yet asserted. After that determination, the Company

BW 921-00016 retained the third-party consultant as described in its disclosures, and ultimately determined that it was able to accrue a liability for potential future asbestos-related claims in accordance with all of the requirements of ASC 450-20-25-2.

Read in the reply
In its next report

First report after the company's reply of Sep 21, 2017: 10-Q filed Oct 26, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

n) Insurance proceeds received · o) Defense costs associated with asbestos related claims
SEC asked (8)
Refer to prior comment 3. Please disclose the range of reasonable possible losses in excess of your asbestos-related accrual as required by ASC 450-20-50-3 and 50-4.
BWA answered
The Company has revised the disclosure proposed to be used in its Form 10-Q for the period ending September 30, 2017 to incorporate this information. A draft of the revised disclosure excerpt is below.

The Company’s estimate of the indemnity and defense costs for asbestos-related claims asserted but not yet resolved and potential claims not yet asserted is its best estimate of such costs. Such estimate is subject to numerous uncertainties. These include future legislative or judicial changes affecting the U.S.
Rest of the answer

tort system, bankruptcy proceedings involving one or more co-defendants, the impact and timing of payments from bankruptcy trusts that presently exist and those that may exist in the future, disease emergence and associated claim filings, the impact of future settlements or significant judgments, changes in the medical condition of claimants, changes in the treatment of asbestos-related disease, and any changes in settlement or defense strategies. The balances recorded for asbestos-related claims are based on best available information and assumptions that the Company believes are reasonable, including as to the number of future claims that may be asserted, the percentage of claims that may result in a payment, the average cost to resolve such claims, and potential defense costs. The Company concluded that it is reasonably possible that it may incur additional losses through 2067 for asbestos-related claims, in addition to amounts recorded, of up to approximately $100 million as of September 30, 2017. The various assumptions utilized in arriving at the Company’s estimate may also change over time, and the Company’s actual liability for asbestos-related claims asserted but not yet resolved and those not yet asserted may be higher or lower than the Company’s estimate as a result of such changes.

Read in the reply
In its next report

First report after the company's reply of Sep 21, 2017: 10-Q filed Oct 26, 2017 ↗, against the 10-Q filed Apr 27, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (1)
During the recent conference call, you asserted that the asbestos liability for unasserted claims relates to approximately 5,400 assumed future claims as of December 31, 2016. Regarding the liability for asserted claims at that date, please tell us how many claims the recorded liability relates to, and whether it is assumed that some of the outstanding claims at that date will be resolved without payment.
BWA answered
The recorded liability relates to approximately 9,400 claims asserted against the Company at December 31, 2016, which represents all claims including those claims asserted prior to 2005. The Company, as disclosed, expects that the vast majority of the asserted claims in which it has been named will be resolved without payment, and projects that only 847 of the 9,400 pending claims would result in payment.
Rest of the answer

We note for the Staff’s ease of reference that the 5,400 assumed future claims referred to in our recent call is net of claims that will be resolved without payment, and that the Company has projected that approximately 27,500 claims will be asserted in the future.

Read in the reply
In its next report

First report after the company's reply of Jan 25, 2018: 10-K filed Feb 8, 2018 ↗, against the 10-K filed Feb 9, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (2)
Please provide us with copies of contemporaneously-prepared written documentation for December 31, 2013, 2014, and 2015 regarding your analysis of unasserted asbestos claims. To the extent asbestos liabilities were discussed in meetings of the board of directors for those periods (either directly or for other purposes such as budgetary purposes), please also provide us with copies of summaries of those discussion
Rest of the question

and related presentation materials.

BWA answered
The Company is providing the materials requested in this Comment and in Comment #3 below under separate cover, with confidential treatment requested for such materials pursuant to 17 C.F.R. 200.83.

As discussed in Company’s prior submissions to the Staff and in the conversations that have been initiated by the Staff respecting this matter, the Company considered many factors in evaluating whether potential unasserted asbestos-related claims were probable and/or reasonably estimable.
Rest of the answer

The determination of whether potential unasserted asbestos-related claims are probable and/or reasonably estimable is inherently difficult, and no one factor controls that determination. There are accordingly numerous contemporaneous documents regarding the Company’s analysis, including internal accounting memoranda, claims data, and similar items. To assist the Staff in reviewing the documentation submitted, the Company has prepared and submitted with the documentation an explanatory matrix (the “Comment 2 Matrix”). The Comment 2 Matrix sets forth the reasons identified by the Company in its prior disclosures and its prior submissions to the Staff as to why the Company determined a liability could not be reasonably accrued for potential unasserted asbestos-related claims in 2013, 2014, and 2015, describes the procedures performed by the Company with respect to each reason identified, and then identifies and describes the particular contemporaneously-prepared documentation that corresponds to each reason. Separate columns further break down that documentation by year (i.e., 2013, 2014, and 2015). Please note that in order to minimize submission of repetitive information to the Staff, we have in some cases provided only one year’s worth of a particular document as an example. The Company may provide the relevant documentation for other years upon request.

The documentation provided under separate cover represents the principal documents that reflect the Company’s analysis of and determination respecting its analysis for accounting purposes of potential unasserted asbestos-related claims. The documentation provided does not purport to represent every document that potentially relates to the Company’s accounting for asbestos-related claims. In addition, the documentation submitted - in particular, the internal accounting memoranda for 2013, 2014, and 2015 - is comprised in part of summary documents to be used by the Company’s management. Such documentation does not, and does not purport to, cover all of the factors considered by the Company’s management in evaluating whether potential unasserted asbestos-related claims were probable and/or reasonably estimable. Many aspects of the Company’s analysis may not have been reduced to writing and may accordingly not be reflected in any document, whether or not provided to the Staff.

In addition, many of the materials requested in this Comment and in Comment #3, below, contain discussions of or references to the Company’s analysis of potential unasserted asbestos-related claims for purposes of financial reporting only in part. Certain of the materials also contain information that is privileged as attorney work product and/or attorney-client communications. The Company has accordingly not provided or redacted, as appropriate, those portions of the materials that do not address its analysis of potential unasserted asbestos-related claims for purposes of financial reporting, or are subject to applicable privilege.

With respect to the Staff’s request in the second sentence of this Comment, the evaluation of potential unasserted asbestos-related claims for accounting purposes has, in the first instance, been undertaken by management with oversight by the Company’s Board of Directors as appropriate. For the years ending December 31, 2013, 2014, and 2015, potential unasserted asbestos-related claims were discussed with the Board of Directors and the Audit Committee as part of broader discussions relating to the Company’s overall assets and liabilities (including asbestos-related assets and liabilities) and their presentation in the Company’s quarterly and annual financial statements. The specific subject of accounting for potential unasserted asbestos-related liabilities and the Company’s historical position that they could not make a reasonable estimate of such claims in those years were not, however, the subject of a separate memorialized discussion with the Board of Directors or presentations to the Board of Directors by the Company during this period. As the Company has previously advised the Staff, management concluded in mid-2016 that it believed a reasonable estimate of potential unasserted asbestos-related claims might then be possible, and the process of attempting to make such an estimation was undertaken by management - with oversight from the Audit Committee of the Board of Directors - at that time.

Read in the reply
In its next report

First report after the company's reply of Jan 25, 2018: 10-K filed Feb 8, 2018 ↗, against the 10-K filed Feb 9, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (3)
Please provide us with copies of all contemporaneously-prepared written documentation regarding your analysis of unasserted asbestos claims as of December 31, 2016, and tell us how this documentation supports that an accrual for unasserted claims first became reasonably estimable at that date.
BWA answered
The Company is providing the materials requested in this Comment under separate cover, with confidential treatment requested for such materials pursuant to 17 C.F.R. 200.83.

The materials provided fall broadly into three categories. The first category of documents consists of three accounting memoranda, one dated August 31, 2016, one dated January 3, 20171, and one dated January 23, 2017, that collectively document the Company’s determination that the accounting standards for a liability accrual on account of potential unasserted asbestos-related claims - i.e., that such claims were both
Rest of the answer

probable and reasonably estimable - might be met, the process by which the Company thereafter sought to make such an estimation and accrue the appropriate liability, and the process in which the Company evaluated its estimate and concluded that an accrual could properly be taken in accordance with applicable accounting rules. The second category of documents consists of minutes of seven (7) meetings of the Audit Committee of the Company’s Board of Directors and two (2) meetings of the Board of Directors itself from July 2016 through February 2017, as the period in which the Company undertook its review process for potential unasserted asbestos-related claims, following the determination by management that the applicable accounting standards might be satisfied. The third and final category of documents consists of four (4) spreadsheets of other contemporaneous documentation relating to the Company’s determination that the accounting standards for a liability accrual on account of potential unasserted asbestos-related claims might be met and the ensuing review process undertaken by the Company to assess and accrue appropriately the amount of such liability.

The Company has previously described for the Staff the reasons why the Company’s management determined that the accounting standards for an accrual for potential unasserted asbestos-related claims - i.e., that such claims were both probable and reasonably estimable - might be met and the process that the Company’s management thereafter followed in attempting to make such an estimate and ultimately accruing the applicable liability. A description of that process is contained in the Company’s original disclosure. The Staff may additionally wish to refer to the September 21 Letter and, in particular, the response to Comment #7 therein for a detailed description of those reasons and supporting commentary. The August 2016

__________________________

1The January 3, 2017 memo was inadvertently mis-dated January 3, 2016.

accounting memorandum supports the Company’s analysis by providing contemporaneous documentation of the results of the Company’s evaluation of the reasons why the applicable accounting standards might then be satisfied and the next steps to be followed. Those steps included, among others, (i) establishing a formalized review process under the oversight of the Company’s Board of Directors, and (ii) the retention of professionals by BorgWarner Morse TEC LLC (the applicable subsidiary of the Company) or its counsel, as applicable, including an actuary, counsel, and supporting specialized accounting professionals, to advise the Company in conducting the review process and, if warranted, appropriately accruing a liability and making the necessary disclosures respecting such an accrual. The meeting minutes of the Audit Committee and the Company’s Board of Directors then detail the conduct of the review process from the establishment of that process in late July 2016 through the finalization of the Company’s 2016 year-end financial statements in February 2017. The Company documented its review of the estimation process, including its review of the data inputs used, the actuary’s output and performance, and the Company’s analysis of the actuary’s work product and incorporation of that work product into its accrual of a liability for potential unasserted asbestos-related claims, in the memoranda dated January 3, 2017 and January 23, 2017, respectively. The spreadsheets submitted by the Company set out the Company’s contemporaneous claims data containing the key claims data reviewed by the Company for the first two quarters of 2016, including by jurisdiction, the number of outstanding claims, new claims filed, claims paid and dismissed, and settlement amounts for the period, as well as comparisons to prior periods.

To address the Staff’s request that the Company “tell us how this documentation supports that an accrual for unasserted claims first became reasonably estimable,” the Company has provided the August 2016 accounting memorandum - as noted above - which supports the Company’s conclusion. The Company has annotated this memorandum to further describe for the Staff how the individual elements of that memorandum support the Company’s conclusions. The Company’s annotations also reference other contemporaneous documentation provided by the Company to the Staff that supports the Company’s conclusion. The Company has annotated this memorandum for the convenience of the Staff in order to answer the second portion of the Staff’s Comment #3 thoroughly, given that the August 2016 memo is the principal document memorializing the Company’s initial determination that a reasonable estimate of its potential unasserted asbestos-related claims might be possible. The minutes of the Audit Committee and Board of Directors meetings provide a self-explanatory overview of the Company’s review process that was performed by management with the oversight of the Audit Committee.

As noted with the Company’s response to Comment #2, above, the documentation provided under separate cover represents the principal documents that reflect the Company’s analysis of and determination respecting its analysis for accounting purposes of potential unasserted asbestos-related claims, in this case from the time the Company’s determined that the accounting standards for a liability accrual on account of potential unasserted asbestos-related claims might be met in mid-2016 through the Company’s decision to accrue such a liability in February 2017 as part of the 2016 year-end financial statements. The documentation provided does not purport to represent every document that relates in any way to the Company’s accounting for potential asbestos-related claims not yet asserted during that period. In addition, the documentation submitted - in particular, the internal accounting memoranda - is comprised in part of summary documents used by the Company’s management. Such documentation does not, and does not purport to, document all of the Company’s deliberations or analysis of this matter, nor does it cover all of the factors considered by the Company’s management in evaluating and concluding whether potential unasserted asbestos-related claims were probable and/or reasonably estimable. Many aspects of the Company’s analysis may not have been reduced to writing and may accordingly not be reflected in any document, whether or not provided to the Staff.

Furthermore, and also as the Company noted in its response to Comment #2, above, many of the materials requested in Comments #2 and #3 contain discussions of or references to the Company’s analysis of potential unasserted asbestos-related claims for purposes of financial reporting only in part. Other portions of such materials are not relevant to the Company’s response to Comment #3 of the Staff. Certain of the materials also contain information that is privileged as attorney work product and/or attorney-client communications. The Company has accordingly not provided or redacted, as appropriate, those portions of the materials that are not relevant or are subject to privilege, as applicable.

Read in the reply
In its next report

First report after the company's reply of Jan 25, 2018: 10-K filed Feb 8, 2018 ↗, against the 10-K filed Feb 9, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (4)
We note from your response letter dated July 10, 2017 (comment 3) that the actuarial central estimate within a range of estimated liabilities was the best estimate of your potential liability for asbestos claims. Please tell us the low end of the range of probable loss for unasserted claims at December 31, 2016.
BWA answered
The Company did not determine a low end of “the range of probable loss” given that ASC 450-20 neither requires nor provides for the accrual or disclosure of such an amount. While the third-party actuary engaged by the Company identified a range of loss, that range of loss incorporated measures of the Company’s estimated liability for potential unasserted asbestos claims that were possible and reflected unlikely events and/or extreme events that were believed to have a remote possibility of occurring.
Rest of the answer

For that reason, the low end of such range would not be considered the low end of a “range of probable loss.”

As the Staff notes, the Company accrued an estimated liability for potential unasserted asbestos claims by utilizing the actuarial central estimate of the range of loss identified by the third-party actuary, consistent with standard estimation methodology. The Company believes, as it has advised the Staff, that this number is a better estimate than any other amount within the range of potential loss utilized by the actuary and therefore is appropriate for accrual in accordance with ASC 450-20-30-1. The Company also determined, as required by ASC 450-20-50-3, that there is a reasonable possibility that a loss may have been incurred in excess of the amount that it accrued. The Company has provided disclosure respecting that potential excess amount of loss beginning with its Form 10-Q for the third quarter of 2017.

In the interests of full disclosure, the Company notes for the Staff that the low end of the range of potential loss for unasserted asbestos claims determined by the actuary was approximately $770 million as of December 31, 2016.

Read in the reply
In its next report

First report after the company's reply of Jan 25, 2018: 10-K filed Feb 8, 2018 ↗, against the 10-K filed Feb 9, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (5)
During the recent conference call, we understand that the Company believes that insurance receivables for amounts under dispute with insurers can be recognized in spite of the rebuttable presumption in ASC 450-20-S99 because court rulings have clarified that the insurance companies are collectively liable even though the amount payable by each insurer may be subject to dispute amongst the insurers.
Rest of the question

Please clarify whether our understanding is correct and elaborate as necessary. Also, please tell us how the creditworthiness of the various insurance companies was considered in your accounting for the insurance recoveries.

BWA answered
The Staff “believes there is a rebuttable presumption that no asset should be recognized for a claim for recovery from a party that is asserting that it is not liable to indemnify the registrant.” See ASC 450-20-S99. That provision states further that “[r]egistrants that overcome that presumption should disclose the amount of recorded recoveries that are being contested and discuss the reasons for concluding that the amounts are probable of recovery.” See id.
Rest of the answer

In considering whether an insurance receivable is probable of recovery, the Company utilizes the definition of “probable” provided in ASC 450-20-20, which provides that an amount is probable of recovery if it is likely to be recovered.

The Company believes that the insurance receivables for the amounts under dispute are probable of recovery, and the rebuttable presumption that no asset should be recognized for a claim for recovery from a party that asserts that it is not liable to indemnify the registrant has been overcome for the following reasons:

• the arguments made by the insurers in the applicable litigation, which have focused principally on disputes such as, for example, whether the coverage available under the insurers’ respective policies has been triggered, the timing on which they have to make payments under those policies, or the share of total liability for which they are responsible, rather than defenses to coverage;

the Company’s and its outside counsel’s evaluation of the arguments made by the insurers in the litigation, which leads the Company and its outside counsel to believe that the insurers’ claims are not meritorious and do not affect whether the amounts that have been accrued as receivables will ultimately be recoverable;

the case law applicable to the insurers’ disputes and the court rulings issued to date in the litigation, which the Company and its counsel view as favorable (such as, for example, the court’s August 2011 “all-sums” ruling that allows BorgWarner Morse TEC LLC (“Morse TEC”) to choose among multiple triggered policies to submit a particular claim to, the court’s December 2011 ruling that the asbestos-related claims against Morse TEC arise from a single “occurrence” under its insurance policies, which allows Morse TEC to access its higher-level excess policies more quickly, and the court’s November 2013 ruling that most of Morse TEC’s primary occurrence limits for asbestos-related claims have been exhausted by payment of claims, which allows for Morse TEC to make claims on the excess policies that are the subject of the insurance litigation);

the absence of any credible evidence alleged by the insurers that they are not liable to indemnify Morse TEC notwithstanding the 13-year pendency of the litigation; and the fact that Morse TEC has successfully recovered on a significant portion of its asbestos-related insurance policies (approximately $270 million) from insurers on account of asbestos-related claims which was favorable to Morse TEC as compared to policy limits - either because the insurers have voluntarily made payments or because a settlement was reached with the insurers - on policies in lower coverage layers that contain similar language to those at issue in the litigation.

Based on these facts, the Company has concluded that the rebuttable presumption in ASC 450-20-S99 is overcome, and that the amount of the insurance receivable remains probable of recovery.

As to the second part of this Comment, the Company monitors the creditworthiness of its insurers on a continual and ongoing basis, and adjustments are made as warranted. This involves assessing the financial strength and stability of insurers by, among other things, reviewing credit ratings by insurer for those carriers for which receivables have been recorded, with additional support from outside counsel. The amounts accrued by the Company in its 2016 financial statements reflect only amounts expected to be recovered from solvent insurers, and not insurers that are insolvent or parties to receivership or similar proceedings. Morse TEC is party to certain insurance policies that are issued by insurance carriers that are insolvent or are parties to receivership or similar proceedings. While Morse TEC may recover amounts in the future on account of those policies, any potential recoveries from insolvent insurers were not considered to be probable of recovery and were not accrued in the Company’s 2016 financial statements.

Read in the reply
In its next report

First report after the company's reply of Jan 25, 2018: 10-K filed Feb 8, 2018 ↗, against the 10-K filed Feb 9, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Note 14: Contingencies · Asbestos-related Liability, page 95
SEC asked (6)
Please tell us why you do not appear to have disclosed the amount of recorded insurance recoveries that are being contested and the reasons why you concluded that the amounts are probable of recovery as specified in ASC 450-20-S99.
BWA answered
As stated in ASC 450-20-S99, “[r]egistrants that overcome the rebuttable presumption in that section should disclose the amount of recorded recoveries that are being contested and discuss the reasons for concluding that the amounts are probable of recovery.” See id. An amount is probable of recovery if it is likely to be recovered.
Rest of the answer

See ASC 450-20-20 (defining “probable”).

The Company discloses in its Form 10-K for 2016 that the insurance-related litigation was filed by “Continental Casualty Company and related companies against the Company and certain of its historical general liability insurers”. The parties to that litigation described in the Company’s Form 10-K represent the large majority of the remaining solvent insurance carriers with whom the Company has coverage. Therefore, the amount of recorded recoveries that is being contested is substantially all of the estimated insurance recoveries respecting asbestos-related claims and defense costs. The Company states in the Risk Factors section of its Form 10-K for 2016 that “[w]hile we have certain insurance coverage available respecting asbestos-related claims asserted against us, most of that insurance coverage is the subject of pending litigation.” The Company also discloses in the footnotes to its 2016 financial statements the separate value of the non-current asset recorded in the amount of $386.4 million in aggregate insurance coverage as of December 31, 2016.

The Company’s disclosure further states that it is “vigorously pursuing the litigation against all the carriers that are parties to it, as well as pursuing settlement discussions with its carriers where appropriate,” and that the Company reviewed “the amount of its potential insurance coverage for [asbestos-related] claims, taking into account the remaining limits of such coverage, the number and amount of claims on our insurance from co-insured parties, [and] ongoing litigation against the Company’s insurers described above,” among other things. The Company additionally disclosed that the amounts it has recorded as insurance receivables “are expected to be fully recoverable.”

The Company believes this disclosure provides adequate information respecting the state of its insurance coverage and the applicable litigation. Notwithstanding that belief, and subject to any developments that may occur in the Cook County litigation, the Company will clarify in its disclosures beginning with its Form 10-K for the year ending December 31, 2017 (expected to be filed on or about February 8, 2018) that the remaining estimated insurance coverage relating to asbestos-related claims and their associated defense costs is the subject of the Cook County insurance litigation. The Company will further clarify its disclosures to say that the Company believes that the insurance receivable is probable of collection notwithstanding that litigation based on, among other things, the arguments made by the insurers in the Cook County litigation (which the Company believes are without merit) and evaluation of those arguments by the Company and its counsel, the case law applicable to the issues in dispute, the rulings to date by the Cook County court, the absence of any credible evidence alleged by the insurers that they are not liable to indemnify the Company, and the fact that the Company has recovered a substantial portion of the insurance coverage (approximately $270 million to date) from insurers under similar policies.

ADDITIONAL ITEMS:

In addition to Comments 1-6 in the Staff’s November 29 Letter, the Staff has also made two verbal requests to the Company for certain information, as follows:

A.

For the claims filed in each year in Column a), please provide claims settled/dismissed/ outstanding as of December 31, 2016; and

B.

For claims settled for each year in Column b), please provide the distribution of years each claim was first asserted.

The references in the Staff’s requests above to “Column a)” or “Column b)” are to columns on Exhibit A to the September 21 Letter.

The Company is providing the materials requested by the Staff under separate cover together with the materials submitted in response to Comments 2 and 3 of the Staff, with confidential treatment requested for such materials pursuant to 17 C.F.R. 200.83.

Read in the reply
In its next report

First report after the company's reply of Jan 25, 2018: 10-K filed Feb 8, 2018 ↗, against the 10-K filed Feb 9, 2017 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2018-10-15

SEC enforcement releases naming BWA

Litigation releases and accounting and auditing enforcement releases (AAER) · sec.gov

1

A release is listed only when SEC's list names BORGWARNER INC (or a name it had before) among those the action is against. The page does not say what the release found: open it on sec.gov. A release against a person at the company, or one that names the company under another spelling, is not matched, so this list can be shorter than SEC's.

Letters without questions

Other letters

UPLOAD and CORRESP
1 other letter: notices that a filing will not be reviewed, requests to declare a registration effective, and the like
  • Aug 8, 2018 · BWA: letter to the SEC · BorgWarner Inc. · Form 10-K for Fiscal Year Ended December 31, 2016 · Filed February...

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 13 letters filed since 2017-05-11. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/BWA/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.